 |
 |
 |
 |
 |
Treatment Name: |
 |
Cyproheptadine and Megestrol in Preventing Weight Loss in Children With Cachexia Caused By Cancer or Cancer Treatment |
 |
 |
 |
 |
Phase: |
 |
Other / Approved |
 |
 |
 |
 |
 |
 |
Treatment ID#: |
 |
1606 NCT00066248 |
 |
 |
 |
 |
Age Group: |
 |
Pediatric Only |
 |
 |
 |
 |
 |
 |
Min Karnofsky Score: |
 |
Not Specified |
 |
 |
 |
 |
Conditions: |
 |
Prior Surgery is Allowed Prior Radiation is Allowed Prior Chemotherapy is Allowed |
 |
 |
 |
 |
 |
 |
Last Updated: |
 |
11/06/2005 |
 |
 |
 |
 |
Tumor Types: |
 |
Acoustic Neuroma Anaplastic Astrocytoma Any Malignant Brain Tumor Brainstem Glioma Craniopharyngioma Ependyoma Ganglioglioma Germ Cell Tumors Glioblastoma Multiforme Gliosarcoma Hemangioblastoma Low Grade Glioma Lymphomas Medulloblastoma Meningioma Metastatic Brain Tumor Mixed Glioma Oligodendroglioma High Grade Oligodendroglioma Low Grade Optic Glioma Pediatric Brain Tumors Pineal Gland Tumor Pituitary Tumors PNET Tumor Recurrent Malignant Pediatric Brain Tumors |
 |
 |
 |
 |
 |
 |
 |
Comments: |
 |
Cyproheptadine and megestrol may improve appetite and help prevent weight loss in children with cancer. |
 |
 |
 |
 |
 |
 |
Treatment Type: |
 |
Chemotherapy Less-Toxics |
 |
 |
 |
 |
Contact: |
 |
Randy Alan Hock MD, PhD, MMM St. Vincent Hospitals and Health Care Centers
Indianapolis, IN 46260 USA Phone: 317-338-4673 Fax: E-mail: Website: |
 |
 |